Skinvisible is Breaking-out as the Level II chart below shows. With the latest trading boosting the Company to a 38.9% gain on the day, total volume is well over the 30 and 90 day volume averages. The latest trade was at 5 cents for a total of 27,000 shares in that one trade alone.
The next ask is at $0.89, which would push SKVI to a much higher gain on the day should that price hit. More than likely there are other orders not shown between the bid at $0.042 and the ask of $0.089. See that below – chart from 3:02 ET today:
Keep your eyes on this one, as SKVI is a great company run by great people. We know them well and have visited with them personally several times over the years.
Contact Skinvisible:
Doreen McMorran
Skinvisible Pharmaceuticals, Inc.
Phone: 702-433-7154
Email: [email protected]
ON THE WEB:
The IR Affiliates network includes:
StockGuru: http://stockguru.com
IR Affiliates: http://www.iraffiliates.com
Penny IR: http://www.stonebridgeiq.com
To feature a company on the Penny IR Network, please contact the Publisher, John Pentony; telephone (469) 358-5200; [email protected].
StockGuru is STOCKGURU.COM. 1601 Berwick Drive, McKinney, Texas 75070 – (469) 252-3030. Disclosure: StockGuru has covered SKVI before for compensation, however, today we are covering this release due to the recent activity in the stock and the significance of the news. StockGuru entered into an investor relations consulting and market awareness contract on July 12, 2010. The company paid us five thousand dollars per month in cash for the period one month. StockGuru was previously compensated 500,000 144 restricted common shares by the company for profile coverage for the period ending January 30, 2010. To avoid all potential conflicts of interest, we never sell shares into the open market during an active market awareness or investor relations program. This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. We hold no shares and will not be receiving further compensation that is share related during this period. StockGuru is not a registered investment adviser or a broker/dealer. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.